Stratasys Releases Fourth Quarter and Full Year 2025 Financial Results
Key Terms
gaap financial
non-gaap financial
adjusted ebitda financial
regulation fd regulatory
-
Fourth quarter revenue of
, compared to$140.0 million in the prior year period$150.4 million -
Fourth quarter GAAP net loss of
, or$18.9 million per diluted share$0.22 -
Fourth quarter Non-GAAP net income of
, or$6.2 million per diluted share$0.07 -
Full year revenue of
, compared to$551.1 million in 2024$572.5 million -
Full year GAAP net loss of
, or$104.3 million per diluted share$1.28 -
Full year Non-GAAP net income increased to
, or$12.7 million per diluted share, over prior year$0.15 or$4.2 million , respectively$0.06 -
Fourth quarter positive operating cash flow of
$4.8 million -
Full year positive operating cash flow of
$15.1 million -
Strong balance sheet with
cash, equivalents and short-term deposits and no debt at year-end 2025$244.5 million -
Fourth quarter Adjusted EBITDA of
,$9.2 million 6.6% of revenue -
Full year Adjusted EBITDA grew
9.6% to ,$28.5 million 5.2% of revenue, compared to ,$26.0 million 4.5% of revenue in 2024 - Provides 2026 outlook
Dr. Yoav Zeif, Stratasys' Chief Executive Officer, stated, “Our fourth quarter performance caps a year in which we successfully maintained our operational discipline and delivered solid cash flow generation, demonstrating the resilience that distinguishes Stratasys. We generated
Dr. Zeif continued, “As we enter 2026, we do so with proven operational excellence, strategic clarity, and the technology portfolio to capitalize on the inevitable return of customer spending. Our commitment to innovation remains unwavering, supported by continued R&D investment and strategic partnerships that provide complete end-to-end solutions. Combined with our strong balance sheet, this positions us to capitalize on inorganic opportunities that we continue to explore, to sustain our technology leadership through strategic investments that will define the next era of digital manufacturing. The stage is set for sustained growth, as customers achieve measurable operational improvements and increase their utilization in true production-scale manufacturing for mission-critical applications.”
Summary - Fourth Quarter 2025 Financial Results Compared to Fourth Quarter 2024:
-
Revenue of
compared to$140.0 million .$150.4 million -
GAAP gross margin of
36.8% , compared to46.3% . -
Non-GAAP gross margin of
46.3% , compared to49.6% . -
GAAP operating loss of
, compared to an operating loss of$20.8 million .$9.7 million -
Non-GAAP operating income of
, compared to operating income of$4.1 million .$9.4 million -
GAAP net loss of
, or$18.9 million per diluted share, compared to a net loss of$0.22 , or$41.9 million per diluted share.$0.59 -
Non-GAAP net income of
, or$6.2 million per diluted share, compared to net income of$0.07 , or$8.5 million per diluted share.$0.12 -
Adjusted EBITDA of
, compared to$9.2 million .$14.5 million -
Cash provided by operating activities of
, compared to$4.8 million .$7.4 million
Summary - 2025 Financial Results Compared to 2024:
-
Revenue of
compared to$551.1 million .$572.5 million -
GAAP gross margin of
41.2% , compared to44.9% . -
Non-GAAP gross margin of
46.9% , compared to49.2% . -
GAAP operating loss of
, compared to an operating loss of$72.5 million .$85.7 million -
Non-GAAP operating income of
, compared to operating income of$8.3 million .$4.9 million -
GAAP net loss of
, or$104.3 million per diluted share, compared to a loss of$1.28 , or$120.3 million per diluted share.$1.70 -
Non-GAAP net income of
, or$12.7 million per diluted share, compared to net income of$0.15 , or$4.2 million per diluted share.$0.06 -
Adjusted EBITDA of
, compared to$28.5 million .$26.0 million -
Cash generated by operating activities of
, compared to$15.1 million .$7.8 million
Financial Outlook:
Based on current market conditions and assuming that the impacts of global inflationary pressures, relatively high interest rates, increased tariffs and other supply chain costs do not impede economic activity further, the Company is providing the following outlook for 2026, which includes an assumption of
-
Full year revenue growing to
to$565 million , improving sequentially through the year.$575 million -
Based on current logistics and materials costs, full year non-GAAP gross margins of
46.7% -47.1% , including approximately of adverse impact from tariffs and foreign exchange rates relative to 2025.$7 million -
Full year non-GAAP operating expenses ranging from
to$260 million , including approximately$262 million of adverse impact from changes in foreign exchange rates.$10 million -
Full year non-GAAP operating margins in a range of
0.7% to1.5% . -
GAAP net loss of
to$83 million , or ($67 million ) to ($0.95 ) per diluted share.$0.76 -
Non-GAAP net income of
to$8 million , or$12.5 million to$0.09 per diluted share.$0.14 -
Adjusted EBITDA of
to$25 million , reflecting Adjusted EBITDA margin of$30 million 4.5% to5.0% . -
Capital expenditures of
to$20 million .$25 million - Expects to generate positive operating cash flow subject to uncertainty around foreign exchange rates and tariffs.
Appropriate reconciliations between historical GAAP and non-GAAP financial measures, as well as between the GAAP and non-GAAP financial measures included in our financial outlook for 2026, are provided in the tables at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures. [We have not included, however, guidance for GAAP gross margin or a reconciliation of our guidance for non-GAAP gross margins to the most directly comparable GAAP financial measure (i.e., GAAP gross margin), as we are unable to do so without unreasonable effort or with reasonable certainty from a quantitative perspective.]
Stratasys Ltd. Fourth Quarter 2025 Webcast and Conference Call Details
The Company plans to webcast its conference call to discuss its fourth quarter and full-year 2025 financial results on Thursday, March 5, 2026, at 8:30 a.m. (ET).
The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com, or directly at the following web address:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=E1fXyUKp
To participate by telephone, the
Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products, healthcare, fashion and education. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.
To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, X/Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the Company’s websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.
Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.
Cautionary Statement Regarding Forward-Looking Statements
The statements in this press release regarding Stratasys' strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2026 and beyond, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the extent of our success at introducing new or improved products and solutions that gain market share; the extent of growth of the 3D printing market generally; the global macro-economic environment, including the impact of increased import tariffs that have been imposed by the
Use of Non-GAAP Financial Measures
The non-GAAP data included herein, but not limited, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations. Our management utilizes these non-GAAP measures to enable us to assess our financial results (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, and legal provisions, (ii) excluding non-cash items such as share-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items, (iii) for certain non-GAAP measures, after eliminating the impact of changes attributable to currency exchange rate fluctuations, and (iv) after excluding changes in revenues solely attributable to divestitures of former subsidiary companies. The items eliminated as part of our calculation of our non-GAAP financial measures either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. Our non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between the GAAP and non-GAAP bases upon which we present our results and financial outlook is provided in the tables below.
| Stratasys Ltd. | ||||||||
| Consolidated Balance Sheets | ||||||||
| ( |
||||||||
| December 31, 2025 | December 31, 2024 | |||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ |
94,527 |
|
$ |
70,200 |
|
||
| Short-term bank deposits |
|
150,000 |
|
|
80,500 |
|
||
| Accounts receivable, net of allowance for credit losses of |
|
160,478 |
|
|
152,979 |
|
||
| Inventories |
|
145,238 |
|
|
179,809 |
|
||
| Prepaid expenses |
|
5,500 |
|
|
7,630 |
|
||
| Other current assets |
|
26,241 |
|
|
21,843 |
|
||
| Total current assets |
|
581,984 |
|
|
512,961 |
|
||
| Non-current assets | ||||||||
| Property, plant and equipment, net |
|
192,566 |
|
|
184,379 |
|
||
| Goodwill |
|
101,599 |
|
|
99,082 |
|
||
| Other intangible assets, net |
|
95,842 |
|
|
106,253 |
|
||
| Operating lease right-of-use assets |
|
25,417 |
|
|
32,169 |
|
||
| Long-term investments |
|
63,104 |
|
|
80,205 |
|
||
| Other non-current assets |
|
13,252 |
|
|
14,697 |
|
||
| Total non-current assets |
|
491,780 |
|
|
516,785 |
|
||
| Total assets | $ |
1,073,764 |
|
$ |
1,029,746 |
|
||
| LIABILITIES AND EQUITY | ||||||||
| Current liabilities | ||||||||
| Accounts payable | $ |
43,021 |
|
$ |
44,977 |
|
||
| Accrued expenses and other current liabilities |
|
34,284 |
|
|
39,749 |
|
||
| Accrued compensation and related benefits |
|
31,304 |
|
|
29,206 |
|
||
| Deferred revenues - short-term |
|
47,835 |
|
|
46,347 |
|
||
| Operating lease liabilities - short-term |
|
6,597 |
|
|
6,935 |
|
||
| Total current liabilities |
|
163,041 |
|
|
167,214 |
|
||
| Non-current liabilities | ||||||||
| Deferred revenues - long-term |
|
19,062 |
|
|
19,057 |
|
||
| Deferred income taxes |
|
312 |
|
|
507 |
|
||
| Operating lease liabilities - long-term |
|
19,903 |
|
|
25,155 |
|
||
| Contingent consideration - long-term |
|
5,353 |
|
|
4,933 |
|
||
| Other non-current liabilities |
|
23,193 |
|
|
19,889 |
|
||
| Total non-current liabilities |
|
67,823 |
|
|
69,541 |
|
||
| Total liabilities | $ |
230,864 |
|
$ |
236,755 |
|
||
| Commitments and contingencies (see note 11) | ||||||||
| Equity | ||||||||
| Ordinary shares, |
$ |
242 |
|
$ |
202 |
|
||
| Treasury shares at cost, 266 thousands shares at December 31, 2025 and 2024 |
|
(1,995 |
) |
|
(1,995 |
) |
||
| Additional paid-in capital |
|
3,275,344 |
|
|
3,123,024 |
|
||
| Accumulated other comprehensive loss |
|
(6,197 |
) |
|
(8,031 |
) |
||
| Accumulated deficit |
|
(2,424,494 |
) |
|
(2,320,209 |
) |
||
| Total equity |
|
842,900 |
|
|
792,991 |
|
||
| Total liabilities and equity | $ |
1,073,764 |
|
$ |
1,029,746 |
|
||
| Stratasys Ltd. | ||||||||||||||||
| Consolidated Statements of Operations | ||||||||||||||||
| ( |
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
||
| Revenues | ||||||||||||||||
| Products | $ |
97,622 |
|
$ |
105,035 |
|
$ |
380,269 |
|
$ |
391,917 |
|
||||
| Services |
|
42,378 |
|
|
45,324 |
|
|
170,833 |
|
|
180,541 |
|
||||
|
140,000 |
|
|
150,359 |
|
|
551,102 |
|
|
572,458 |
|
|||||
| Cost of revenues | ||||||||||||||||
| Products |
|
60,782 |
|
|
53,587 |
|
|
206,475 |
|
|
197,807 |
|
||||
| Services |
|
27,757 |
|
|
27,083 |
|
|
117,341 |
|
|
117,835 |
|
||||
|
88,539 |
|
|
80,670 |
|
|
323,816 |
|
|
315,642 |
|
|||||
| Gross profit |
|
51,461 |
|
|
69,689 |
|
|
227,286 |
|
|
256,816 |
|
||||
| Operating expenses | ||||||||||||||||
| Research and development, net |
|
18,030 |
|
|
24,785 |
|
|
77,304 |
|
|
99,142 |
|
||||
| Selling, general and administrative |
|
54,192 |
|
|
54,604 |
|
|
222,471 |
|
|
243,335 |
|
||||
|
72,222 |
|
|
79,389 |
|
|
299,775 |
|
|
342,477 |
|
|||||
| Operating loss |
|
(20,761 |
) |
|
(9,700 |
) |
|
(72,489 |
) |
|
(85,661 |
) |
||||
| Financial income, net |
|
2,971 |
|
|
176 |
|
|
10,386 |
|
|
1,676 |
|
||||
| Loss before income taxes |
|
(17,790 |
) |
|
(9,524 |
) |
|
(62,103 |
) |
|
(83,985 |
) |
||||
| Income tax expenses |
|
1,062 |
|
|
653 |
|
|
3,082 |
|
|
2,973 |
|
||||
| Share in losses of associated companies and impairment charges |
|
- |
|
|
31,766 |
|
|
39,100 |
|
|
33,325 |
|
||||
| Net loss | $ |
(18,852 |
) |
$ |
(41,943 |
) |
$ |
(104,285 |
) |
$ |
(120,283 |
) |
||||
| Net loss per ordinary share - basic and diluted | $ |
(0.22 |
) |
$ |
(0.59 |
) |
$ |
(1.28 |
) |
$ |
(1.70 |
) |
||||
| Weighted average ordinary shares outstanding - basic and diluted |
|
85,671 |
|
|
71,406 |
|
|
81,602 |
|
|
70,858 |
|
||||
| Stratasys Ltd. | ||||||||||||||||||||||
| Reconciliation of GAAP to Non-GAAP Results of Operations | ||||||||||||||||||||||
| Three Months Ended December 31, | ||||||||||||||||||||||
|
2025 |
|
|
Non-GAAP |
|
2025 |
|
|
2024 |
|
|
Non-GAAP |
|
2024 |
||||||||
| GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | |||||||||||||||||
| Gross profit (1) | $ |
51,461 |
|
$ |
13,393 |
|
$ |
64,854 |
$ |
69,689 |
|
$ |
4,866 |
|
$ |
74,555 |
||||||
| Operating income (loss) (1,2) |
|
(20,761 |
) |
|
24,853 |
|
|
4,092 |
|
(9,700 |
) |
|
19,144 |
|
|
9,444 |
||||||
| Net income (loss) (1,2,3) |
|
(18,852 |
) |
|
25,034 |
|
|
6,182 |
|
(41,943 |
) |
|
50,462 |
|
|
8,519 |
||||||
| Net income (loss) per diluted share (4) | $ |
(0.22 |
) |
$ |
0.29 |
|
$ |
0.07 |
$ |
(0.59 |
) |
$ |
0.71 |
|
$ |
0.12 |
||||||
(1) |
Acquired intangible assets amortization expenses |
|
4,749 |
|
|
4,496 |
|
|||||||||||||||
|
Non-cash share-based compensation expenses |
|
772 |
|
|
198 |
|
|||||||||||||||
|
Restructuring and other expenses |
|
7,872 |
|
|
172 |
|
|||||||||||||||
|
|
13,393 |
|
|
4,866 |
|
||||||||||||||||
|
||||||||||||||||||||||
(2) |
Acquired intangible assets amortization expenses |
|
1,198 |
|
|
1,153 |
|
|||||||||||||||
|
Non-cash share-based compensation expenses |
|
5,516 |
|
|
2,856 |
|
|||||||||||||||
|
Restructuring and other related costs |
|
1,263 |
|
|
5,275 |
|
|||||||||||||||
|
Revaluation of investment |
|
- |
|
|
4,697 |
|
|||||||||||||||
|
Contingent consideration |
|
436 |
|
|
(9,148 |
) |
|||||||||||||||
|
Net loss from sale of investment |
|
- |
|
|
4,760 |
|
|||||||||||||||
|
Legal and other expenses |
|
3,047 |
|
|
4,685 |
|
|||||||||||||||
|
|
11,460 |
|
|
14,278 |
|
||||||||||||||||
|
|
24,853 |
|
|
19,144 |
|
||||||||||||||||
|
||||||||||||||||||||||
(3) |
Corresponding tax effect |
|
558 |
|
|
535 |
|
|||||||||||||||
|
Equity method related expenses and impairment |
|
- |
|
|
30,910 |
|
|||||||||||||||
|
Finance income |
|
(377 |
) |
|
(127 |
) |
|||||||||||||||
|
$ |
25,034 |
|
$ |
50,462 |
|
||||||||||||||||
|
||||||||||||||||||||||
(4) |
Weighted average number of ordinary shares outstanding - Diluted |
|
85,671 |
|
|
86,311 |
|
71,406 |
|
|
71,740 |
|||||||||||
| Stratasys Ltd. | ||||||||||||||||||||||
| Twelve Months Ended December 31, | ||||||||||||||||||||||
|
2025 |
|
|
Non-GAAP |
|
2025 |
|
|
2024 |
|
|
Non-GAAP |
|
2024 |
||||||||
| GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | |||||||||||||||||
| Gross profit (1) | $ |
227,286 |
|
$ |
31,097 |
|
$ |
258,383 |
$ |
256,816 |
|
$ |
24,948 |
|
$ |
281,764 |
||||||
| Operating income (loss) (1,2) |
|
(72,489 |
) |
|
80,820 |
|
|
8,331 |
|
(85,661 |
) |
|
90,594 |
|
|
4,933 |
||||||
| Net income (loss) (1,2,3) |
|
(104,285 |
) |
|
117,000 |
|
|
12,715 |
|
(120,283 |
) |
|
124,520 |
|
|
4,237 |
||||||
| Net income (loss) per diluted share (4) | $ |
(1.28 |
) |
$ |
1.43 |
|
$ |
0.15 |
$ |
(1.70 |
) |
$ |
1.76 |
|
$ |
0.06 |
||||||
(1) |
Acquired intangible assets amortization expenses |
|
18,280 |
|
|
18,576 |
|
|||||||||||||||
|
Non-cash share-based compensation expenses |
|
3,045 |
|
|
3,072 |
|
|||||||||||||||
|
Restructuring and other expenses |
|
9,772 |
|
|
3,300 |
|
|||||||||||||||
|
|
31,097 |
|
|
24,948 |
|
||||||||||||||||
|
||||||||||||||||||||||
(2) |
Acquired intangible assets amortization expenses |
|
4,121 |
|
|
5,847 |
|
|||||||||||||||
|
Non-cash share-based compensation expenses |
|
21,229 |
|
|
22,546 |
|
|||||||||||||||
|
Restructuring and other related costs |
|
5,494 |
|
|
17,419 |
|
|||||||||||||||
|
Revaluation of investments |
|
2,208 |
|
|
6,597 |
|
|||||||||||||||
|
Contingent consideration |
|
1,724 |
|
|
(7,595 |
) |
|||||||||||||||
|
Net loss from sale of investment |
|
- |
|
|
4,760 |
|
|||||||||||||||
|
Legal and other expenses |
|
14,947 |
|
|
16,072 |
|
|||||||||||||||
|
|
49,723 |
|
|
65,646 |
|
||||||||||||||||
|
|
80,820 |
|
|
90,594 |
|
||||||||||||||||
|
||||||||||||||||||||||
(3) |
Corresponding tax effect |
|
1,015 |
|
|
1,267 |
|
|||||||||||||||
|
Equity method related expenses and impairment |
|
36,245 |
|
|
31,262 |
|
|||||||||||||||
|
Finance expenses (income) |
|
(1,080 |
) |
|
1,397 |
|
|||||||||||||||
|
$ |
117,000 |
|
$ |
124,520 |
|
||||||||||||||||
|
||||||||||||||||||||||
(4) |
Weighted average number of ordinary shares outstanding - Diluted |
|
81,602 |
|
|
82,301 |
|
70,858 |
|
|
71,177 |
|||||||||||
| Stratasys Ltd. | |||||||||||||
| Reconciliation of GAAP net loss to Adjusted EBITDA | |||||||||||||
| Three months ended December 31, |
Twelve months ended December 31, |
||||||||||||
|
2025 |
|
|
2024 |
|
|
|
2025 |
|
|
2024 |
|
|
| Net loss | $ |
(18,852 |
) |
|
(41,943 |
) |
$ |
(104,285 |
) |
$ |
(120,283 |
) |
|
| Financial income, net |
|
(2,971 |
) |
|
(176 |
) |
|
(10,386 |
) |
|
(1,676 |
) |
|
| Income tax expenses |
|
1,062 |
|
|
653 |
|
|
3,082 |
|
|
2,973 |
|
|
| Share in losses of associated companies and impairment charges |
|
- |
|
|
31,766 |
|
|
39,100 |
|
|
33,325 |
|
|
| Depreciation expenses |
|
5,190 |
|
|
5,033 |
|
|
20,738 |
|
|
21,030 |
|
|
| Amortization expenses |
|
5,954 |
|
|
5,649 |
|
|
22,435 |
|
|
24,423 |
|
|
| Non-cash share-based compensation expenses |
|
6,288 |
|
|
3,054 |
|
|
24,274 |
|
|
25,618 |
|
|
| Revaluation of investments |
|
- |
|
|
4,697 |
|
|
2,208 |
|
|
6,597 |
|
|
| Net loss from sale of investment |
|
- |
|
|
4,760 |
|
|
- |
|
|
4,760 |
|
|
| Contingent consideration |
|
436 |
|
|
(9,148 |
) |
|
1,724 |
|
|
(7,595 |
) |
|
| Legal and other expenses |
|
3,915 |
|
|
4,685 |
|
|
15,935 |
|
|
16,072 |
|
|
| Restructuring and other related costs |
|
8,155 |
|
|
5,447 |
|
|
13,695 |
|
|
20,719 |
|
|
| Adjusted EBITDA | $ |
9,177 |
|
$ |
14,477 |
|
$ |
28,520 |
|
$ |
25,963 |
|
|
| Stratasys Ltd. | |
| Reconciliation of GAAP Net Loss to Non-GAAP Net Income Forward Looking Guidance: | |
| Fiscal Year 2026 | |
| ( |
Low High |
| GAAP net loss | |
| Adjustments | |
| Share-based compensation expenses | |
| Intangible assets amortization expenses | |
| Reorganization and other | |
| Tax expenses related to Non-GAAP adjustments | |
| Non-GAAP net income | |
| GAAP loss per share | |
| Non-GAAP diluted earnings per share | |
| Reconciliation of GAAP Net Loss to Adjusted EBITDA Forward Looking Guidance: | |
| Fiscal Year 2026 | |
| ( |
Low High |
| GAAP net loss | |
| Adjustments | |
| Share-based compensation expenses | |
| Intangible assets amortization expenses | |
| Reorganization and other | |
| Tax expenses related to Non-GAAP adjustments | |
| Other non-operating income | |
| Depreciation | |
| Adjusted EBITDA | |
| Stratasys Ltd. | |
| Reconciliation of GAAP Operating Loss to Non-GAAP Operating Income Forward Looking Guidance: | |
| Fiscal Year 2026 | |
| ( |
Low High |
| GAAP operating loss | |
| GAAP operating margins | (15)% to (12)% |
| Adjustments | |
| Share-based compensation expenses | |
| Intangible assets amortization expenses | |
| Reorganization and other | |
| Non-GAAP operating profit | |
| Non-GAAP operating margins | 0.7 % to |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260305568607/en/
Yonah Lloyd
CCO & VP Investor Relations
Yonah.Lloyd@stratasys.com
Source: Stratasys Ltd.